Ortho RTi

Biologics

Chris J. StewartSeptember 25, 2020
416

Ortho Regenerative Technologies Reports its Second Quarter 2021 Results

MONTREAL, Sept. 25, 2020 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging orthobiologics company, today reported…
Read More »
Biologics

Josh SandbergJuly 28, 2020
801

Ortho Regenerative Technologies Releases New Positive Histology Results From Pivotal Preclinical GLP Rotator Cuff Tear Repair Efficacy Study in Large-Animal Model

MONTREAL, July 23, 2020 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging orthobiologics company, today announced new positive results following completion of its pivotal preclinical study report…
Read More »
Biologics

Chris J. StewartMarch 13, 2020
1,205

Ortho Regenerative Technologies Announces Positive Results from Pivotal Preclinical Study in Rotator Cuff Tear Repair

Safety profile of ORTHO-R confirmed.Statistical significance over standard of care demonstrated.ORTHO-R program advancing towards clinical phase. MONTREAL, March 12, 2020 /CNW/ – Ortho…
Read More »
Sports Medicine

DrueJune 17, 2019
1,875

Ortho Regenerative Technologies Announces Changes in Executive Leadership

KIRKLAND, QC, June 17, 2019 /CNW Telbec/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Company”), an emerging Orthopaedic and…
Read More »
Sports Medicine

Josh SandbergFebruary 11, 2019
1,667

Ortho RTi Announces Initiation of Pivotal Study on Ortho-R for Rotator Cuff Repair

KIRKLAND, QC, Feb. 11, 2019 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Company”), an emerging Orthopaedic and Sports…
Read More »
Sports Medicine

Josh SandbergFebruary 4, 2019
1,525

Ortho RTi Announces More Prestigious Scientific Validation

KIRKLAND, QC, Feb. 4, 2019 /PRNewswire/ – Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Company”), an emerging Orthopaedic and Sports Medicine Technology…
Read More »
Financial

Josh SandbergSeptember 20, 2018
1,065

Ortho Regenerative Technologies Inc. Appoints Accomplished Life Science Executive, Luc Mainville, as CFO

KIRKLAND, Quebec, Sept. 19, 2018 (GLOBE NEWSWIRE) — Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Corporation”) (CSE: ORTH) today…
Read More »
Sports Medicine

Josh SandbergSeptember 5, 2018
1,363

Ortho Regenerative Technologies Inc. Announces CFO Change

KIRKLAND, Quebec, Aug. 31, 2018 (GLOBE NEWSWIRE) — Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Corporation”) announces…
Read More »
Hospitals

Josh SandbergMay 24, 2018
1,238

Ortho RTi Receives Notice of Allowance for Second European Patent Protecting Ortho-R Technology

KIRKLAND, QC, May 23, 2018 /CNW/ – Ortho Regenerative Technologies Inc. (CSE: ORTH.CN) (“Ortho RTi” or the “Corporation“), an emerging Orthopaedic and…
Read More »
Sports Medicine

Josh SandbergMarch 12, 2018
10,287

Ortho RTi Receives Notice of Allowance for European Patent Protecting Ortho-R Technology

KIRKLAND, QC, March 8, 2018 /CNW Telbec/ – Ortho Regenerative Technologies Inc. (CSE: ORTH.CN) (“Ortho RTi” or the “Corporation”), an emerging Orthopaedic and…
Read More »
Uncategorized

Josh SandbergNovember 25, 2015
2,432

Ortho RTi Announces the Filing of a Preliminary Prospectus

KIRKLAND, QC, Nov. 24, 2015 /CNW Telbec/ – Ortho Regenerative Technologies Inc. (“Ortho RTi”), a Canadian orthopaedic biotechnology company, announced today that it…
Read More »
Financial

Josh SandbergAugust 12, 2015
1,638

Ortho RTi Announces Acquisition of Regenerative Medicine Technology

KIRKLAND, QC, Aug. 11, 2015 /CNW Telbec/ – Ortho Regenerative Technologies Inc., a privately held Canadian biotechnology company, is pleased to announce that…
Read More »